Skip to main content
logo
Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden flag Sweden · Delayed Price · Currency is SEK
9.56
-0.16 (-1.65%)
Aug 13, 2026, 5:23 PM CET

Xbrane Biopharma AB Revenue

Xbrane Biopharma AB had revenue of 17.34M SEK in the quarter ending March 31, 2026, a decrease of -81.41%. This brings the company's revenue in the last twelve months to 76.45M, down -66.36% year-over-year. In the year 2025, Xbrane Biopharma AB had annual revenue of 152.35M with 2.87% growth.

Revenue (ttm)
76.45M
Revenue Growth
-66.36%
P/S Ratio
2.36
Revenue / Employee
2.87M
Employees
29
Market Cap
196.99M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025152.35M4.26M2.87%
Dec 31, 2024148.10M-90.63M-37.96%
Dec 31, 2023238.73M181.11M314.33%
Dec 31, 202257.62M46.91M438.03%
Dec 31, 202110.71M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 201820.49M-286.00K-1.38%
Dec 31, 201720.77M--
Dec 31, 2016---
Dec 31, 2015392.86K203.23K107.17%
Dec 31, 2014189.63K104.000.05%
Dec 31, 2013189.52K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
IRLAB Therapeutics AB92.46M
Nanologica AB31.83M
Alzinova AB25.66M
Biovica International AB13.49M
Abera Bioscience AB11.83M
Elicera Therapeutics AB10.64M
Simris Group AB (PUBL)3.59M
Xintela AB2.59M
Revenue Rankings

Xbrane Biopharma AB News

More News